Whereas lung cancer is the leading cause of cancer-related death among individuals in the United States, accounting for more deaths than breast cancer, prostate cancer, and melanoma cancer combined; Whereas it is estimated that, in 2023, 238,340 individuals in the United States will be diagnosed with lung cancer, and an estimated 127,070 individuals (approximately 350 individuals per day) will die from the disease; Whereas 1 in 16 men and 1 in 17 women in the United States will develop lung cancer during their lifetimes; Whereas the rate of lung cancer diagnosis in women in the United States has increased by 84 percent over the past 42 years and each year more women die from lung cancer than breast cancer and ovarian cancer combined; Whereas disparities in lung cancer screening, diagnosis, treatment, and mortality are well-documented, and Black men have the highest incidence of lung cancer and the highest mortality rate from lung cancer of any racial or ethnic group in the United States; Whereas in 2023, lung cancer in individuals who have never smoked is estimated to account for 20,500 deaths in the United States; Whereas women who have never smoked are more likely to be diagnosed with lung cancer than men who have never smoked; Whereas in the United States, the proportion of lung cancers diagnosed in individuals who have never smoked is increasing, especially among younger women; Whereas the 5-year survival rate for localized lung cancer is 62.8 percent, yet only 23.3 percent of lung cancers are diagnosed at this stage, while a majority of lung cancer cases are diagnosed at the distant stage, for which the 5-year survival rate is 8.2 percent; Whereas screening individuals at high risk of lung cancer using low-dose computed tomography can detect lung cancer earlier than other forms of screening and ultimately save lives